Indexed in

License and use

Citations

Cited 5 times in

Altmetrics

Grant support

This study was supported by a public grant attributed by the French Agence Nationale de la Recherche (ANR) as part of the second "Investissements d'Avenir" program (reference: ANR-17-RHUS-0003) to FZ and by "Investissement d'avenir" Laboratoires d'Excellence (LabEx) DEVweCAN (Cancer Development and Targeted Therapies) grant ANR-10-LABX-61 to FZ and BT; by Agence Nationale de Recherches sur le SIDA, les Hepatites Virales et les Maladies Infectieuses Emergentes (ANRS MIE) grant ECTZ75178 to BT and CB and fellowship ECTZ161842 to GG.

Analysis of institutional authors

Share

Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes

Publicated to:Journal Of Hepatology. 81 (4): - 2024-09-16 81(4), DOI: 10.1016/j.jhep.2024.05.016

Authors: Chapus, Fleur; Giraud, Guillaume; Huchon, Pelagie; Roda, Melanie; Grand, Xavier; Charre, Caroline; Goldsmith, Chloe; Suarez, Armando Andres Roca; Martinez, Maria-Guadalupe; Fresquet, Judith; Diederichs, Audrey; Locatelli, Maelle; Polveche, Helene; Scholtes, Caroline; Chemin, Isabelle; Vargas, Hector Hernandez; Rivoire, Michel; Bourgeois, Cyril F; Zoulim, Fabien; Testoni, Barbara

Affiliations

Abstract

Background & Aims: Transcription termination fine-tunes gene expression and contributes to the specification of RNA function in eukaryotic cells. Transcription termination of HBV is subject to the recognition of the canonical polyadenylation signal (cPAS) common to all viral transcripts. However, the regulation of this cPAS and its impact on viral gene expression and replication is currently unknown. Methods: To unravel the regulation of HBV transcript termination, we implemented a 3' RACE (rapid amplification of cDNA ends)PCR assay coupled to single molecule sequencing both in in vitro-infected hepatocytes and in chronically infected patients. Results: The detection of a previously unidentified transcriptional readthrough indicated that the cPAS was not systematically recognized during HBV replication in vitro and in vivo. . Gene expression downregulation experiments demonstrated a role for the RNA helicases DDX5 and DDX17 in promoting viral transcriptional readthrough, which was, in turn, associated with HBV RNA destabilization and decreased HBx protein expression. RNA and chromatin immunoprecipitation, together with mutation of the cPAS sequence, suggested a direct role of DDX5 and DDX17 in functionally linking cPAS recognition to transcriptional read- through, HBV RNA stability and replication. Conclusions: Our findings identify DDX5 and DDX17 as crucial determinants of HBV transcriptional fidelity and as host restriction factors for HBV replication. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.

Keywords